A Food and Drug Administration panel on Wednesday recommended that makers of testosteronereplacement drugs study possible increased risks of heart attack and stroke from the hotselling products The outside panel of experts also voted overwhelmingly that the FDA should come up with language in the products labels to restrict the intended uses of the drugs which critics say are overprescribed The decision could have implications for millions of older men taking the medicines